A Novel Hydrogen Sulfide Donor Reduces Pilocarpine-Induced Status Epilepticus and Regulates Microglial Inflammatory Profile
Although epilepsy is one of the most common neurologic disorders, there is still a lack of effective therapeutic drugs for it. Recently, we synthesized a novel hydrogen sulfide (H2S) donor, which is found to reduce seizures in animal models effectively. But it remains to be determined for its mechan...
Saved in:
Main Authors: | Zhongrui Liu, Ziting Zhu, Yan He, Qiyun Kang, Fei Li, Wenlong Zhang, Yuehua He, Yuwan Lin, Baoyi Huang, Mingshu Mo, Pingyi Xu, Xiaoqin Zhu |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/4deb0b1dea884317bb4c24f270ce7f5a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nonconvulsive status epilepticus
Published: (2009) -
Characterization of mouse salivary polypeptide secretion after oral administration of pilocarpine
by: LÓPEZ-SOLÍS,REMIGIO, et al.
Published: (2001) -
Combinations of Pilocarpine and Oxymetazoline for the Pharmacological Treatment of Presbyopia
by: Francis W. Price, Jr., MD, et al.
Published: (2021) -
Substantial outcome improvement using a refined pilocarpine mouse model of temporal lobe epilepsy
by: Alexandre Vigier, et al.
Published: (2021) -
Status Epilepticus Mortality Risk Factors and a Correlation Survey with the Newly Modified STESS
by: Tzu-Hsin Huang, et al.
Published: (2021)